Paul R. Rhomberg

Overview

Best Publications

• Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995

  Gary V. Doern;Kristopher P. Heilmann;Holly K. Huynh;Paul R. Rhomberg

  781
  Citations

• Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).

  Paul R. Rhomberg;Ronald N. Jones

  246
  Citations

• In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

  Akinobu Ito;Naoki Kohira;Samuel K. Bouchillon;Joshua West

  220
  Citations

• Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995

  Angela B. Brueggemann;Stacy L. Coffman;Paul Rhomberg;Holly Huynh

  200
  Citations

• Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

  Lalitagauri M. Deshpande;Paul R. Rhomberg;Helio S. Sader;Ronald N. Jones

  197
  Citations

• Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes

  Helio S. Sader;Paul R. Rhomberg;David J. Farrell;Ronald N. Jones

  191
  Citations

• Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).

  Mariana Castanheira;Shawn A. Messer;Paul R. Rhomberg;Michael A. Pfaller

  178
  Citations

• Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

  Janet I. Andrews;Daniel J. Diekema;Stephen K. Hunter;Paul R. Rhomberg

  169
  Citations

• Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

  Mariana Castanheira;Paul R. Rhomberg;Robert K. Flamm;Ronald N. Jones

  167
  Citations

• Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.

  Michael A Pfaller;Paul R Rhomberg;Shawn A Messer;Ronald N Jones

  154
  Citations

• Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001)

  Alan H. Mutnick;Paul R. Rhomberg;Helio S. Sader;Ronald N. Jones

  146
  Citations

• Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

  Helio S. Sader;Paul R. Rhomberg;Ronald N. Jones

  143
  Citations

• Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).

  Paul R. Rhomberg;Thomas R. Fritsche;Helio S. Sader;Ronald N. Jones

  142
  Citations

• Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.

  Mariana Castanheira;Lalitagauri M. Deshpande;Andrew P. Davis;Paul R. Rhomberg

  134
  Citations

• Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).

  Mariana Castanheira;Rodrigo E. Mendes;Paul R. Rhomberg;Ronald N. Jones

  127
  Citations

• Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

  Michael A. Pfaller;Shawn A. Messer;Paul R. Rhomberg;Ronald N. Jones

  122
  Citations

• Outbreak of Severe Pseudomonas aeruginosa Infections Caused by a Contaminated Drain in a Whirlpool Bathtub

  Yasmina F. Berrouane;Louise-Anne McNutt;Barry J. Buschelman;Paul R. Rhomberg

  122
  Citations

• WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.

  Helio S Sader;Paul R Rhomberg;Robert K Flamm;Ronald N Jones

  119
  Citations

• Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods

  Michael J. Rybak;Celine Vidaillac;Helio S. Sader;Paul R. Rhomberg

  113
  Citations

• In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

  Michael A. Pfaller;Shawn A. Messer;Paul R. Rhomberg;Ronald N. Jones

  113
  Citations